Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Introducing of novel class of pyrano[2,3-c]pyrazole-5-carbonitrile analogs with potent antimicrobial activity, DNA gyrase inhibition, and prominent pharmacokinetic and CNS toxicity profiles supported by molecular dynamic simulation.
Almaghrabi M, Musa A, Aljohani AKB, Ahmed HEA, Alsulaimany M, Miski SF, Mostafa EM, Hussein S, Parambi DGT, Ghoneim MM, Elgammal WE, Halawa AH, Hammad A, El-Agrody AM. Almaghrabi M, et al. Among authors: alsulaimany m. J Biomol Struct Dyn. 2024 Nov;42(18):9529-9546. doi: 10.1080/07391102.2023.2252088. Epub 2023 Sep 3. J Biomol Struct Dyn. 2024. PMID: 37661733
Modulation of NRF2/KEAP1-Mediated Oxidative Stress for Cancer Treatment by Natural Products Using Pharmacophore-Based Screening, Molecular Docking, and Molecular Dynamics Studies.
Alzain AA, Mukhtar RM, Abdelmoniem N, Shoaib TH, Osman W, Alsulaimany M, Aljohani AKB, Almadani SA, Alsaadi BH, Althubyani MM, Mohamed SGA, Mohamed GA, Ibrahim SRM. Alzain AA, et al. Among authors: alsulaimany m. Molecules. 2023 Aug 10;28(16):6003. doi: 10.3390/molecules28166003. Molecules. 2023. PMID: 37630254 Free PMC article.
Sulfonamide-Pyrazole derivatives as next-generation Cyclooxygenase-2 enzyme inhibitors: From molecular design to in vivo efficacy.
Elgohary MK, Elkotamy MS, Alkabbani MA, El Hassab MA, Al-Rashood ST, Binjubair FA, Alsulaimany M, Ghabbour HA, Eldehna WM, Abdel-Aziz HA. Elgohary MK, et al. Among authors: alsulaimany m. Int J Biol Macromol. 2024 Dec 28;293:139170. doi: 10.1016/j.ijbiomac.2024.139170. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39736293
Rational design and synthesis of novel phenyltriazole derivatives targeting MRSA cell wall biosynthesis.
Elsebaei MM, Ezzat HG, Helal AM, El-Shershaby MH, Abdulrahman MS, Alsedawy M, Aljohani AKB, Almaghrabi M, Alsulaimany M, Almohaywi B, Alghamdi R, Miski SF, Musa A, Ahmed HEA. Elsebaei MM, et al. Among authors: alsulaimany m. RSC Adv. 2024 Dec 20;14(54):39977-39994. doi: 10.1039/d4ra07367c. eCollection 2024 Dec 17. RSC Adv. 2024. PMID: 39713184 Free PMC article.
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR-2 and EGFRT790M: Molecular docking, ADMET, design, and syntheses.
Alsulaimany M, El-Hddad SSA, Akrim ZSM, Aljohani AKB, Almohaywi B, Alatawi OM, Almadani SA, Alharbi HY, Aljohani MS, Miski SF, Alghamdi R, El-Adl K. Alsulaimany M, et al. Arch Pharm (Weinheim). 2024 Nov;357(11):e2400389. doi: 10.1002/ardp.202400389. Epub 2024 Aug 1. Arch Pharm (Weinheim). 2024. PMID: 39088827
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking.
Aljohani AKB, El-Adl K, Almohaywi B, Alatawi OM, Alsulaimany M, El-Morsy A, Almadani SA, Alharbi HY, Aljohani MS, Abdulhaleem M FA, Osman HEM, Mohamady S. Aljohani AKB, et al. Among authors: alsulaimany m. RSC Adv. 2024 Mar 6;14(12):7964-7980. doi: 10.1039/d4ra00502c. eCollection 2024 Mar 6. RSC Adv. 2024. PMID: 38454937 Free PMC article.
Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors.
Alsulaimany M, El-Adl K, Aljohani AKB, Alharbi HY, Alatawi OM, Aljohani MS, El-Morsy A, Almadani SA, Alsimaree AA, Salama SA, Keshek DE, Mohamed AA. Alsulaimany M, et al. RSC Adv. 2023 Dec 13;13(51):36301-36321. doi: 10.1039/d3ra07700d. eCollection 2023 Dec 8. RSC Adv. 2023. PMID: 38093733 Free PMC article.
Design of new Mcl-1 inhibitors for cancer using fragments hybridization, molecular docking, and molecular dynamics studies.
Alzain AA, Elbadwi FA, Mukhtar RM, Shoaib TH, Abdelmoniem N, Miski SF, Ghazawi KF, Alsulaimany M, Mohamed SGA, Ainousah BE, Hussein HGA, Mohamed GA, Ibrahim SRM. Alzain AA, et al. Among authors: alsulaimany m. J Biomol Struct Dyn. 2025 Jan;43(1):386-398. doi: 10.1080/07391102.2023.2281637. Epub 2023 Nov 14. J Biomol Struct Dyn. 2025. PMID: 37962580
11 results